Cormorant Asset Management, LP

Holdings History for Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS)

Symbol: KROS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2023		-0.32%	$0	0	-100,000	-100%	$15.52	Q1 2023
31 Dec 2022	0.32%	0%	$4,802,000	100,000	0		$48.02	Q4 2022
30 Sep 2022	0.26%	0%	$3,762,000	100,000	0		$37.62	Q3 2022
30 Jun 2022	0.21%	0%	$2,763,000	100,000	0		$27.63	Q2 2022
31 Mar 2022	0.42%	-0.21%	$5,438,000	100,000	-50,000	-33%	$54.38	Q1 2022
31 Dec 2021	0.52%	+0.52%	$8,776,000	150,000	+150,000	NEW	$58.51	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.